A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic Diseases.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
19 06 2019
Historique:
received: 21 11 2018
accepted: 01 03 2019
pubmed: 6 3 2019
medline: 25 2 2020
entrez: 6 3 2019
Statut: ppublish

Résumé

To systematically test whether coinfections spread along the HIV-1 transmission network and whether similarities in HIV-1 genomes predict AIDS-defining illnesses and comorbidities, we analyzed the distribution of these variables on the HIV phylogeny of the densely sampled Swiss HIV Cohort Study. By combining different statistical methods, we could detect, quantify, and explain the clustering of diseases. Infectious conditions such as hepatitis C, but also Kaposi sarcoma, clustered significantly, suggesting transmission of these infections along the HIV-1 transmission network. The clustering of patients with neurocognitive complaints could not be completely explained by the clustering of patients with similar demographic risk factors, which suggests a potential impact of viral genetics. In summary, the consistent and robust signal for coinfections and comorbidities highlights the strong interaction of HIV-1 and other infections and shows the potential of combining phylogenetic methods to identify disease traits that are likely to be related to virus genetic factors.

Identifiants

pubmed: 30835292
pii: 5369724
doi: 10.1093/infdis/jiz093
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

244-253

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Katharina Kusejko (K)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Switzerland.

Nadine Bachmann (N)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Switzerland.

Sandra E Chaudron (SE)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Switzerland.

Huyen Nguyen (H)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Switzerland.

Dominique L Braun (DL)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Switzerland.

Benjamin Hampel (B)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Switzerland.

Manuel Battegay (M)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland.

Enos Bernasconi (E)

Division of Infectious Diseases, Regional Hospital Lugano, Switzerland.

Alexandra Calmy (A)

Laboratory of Virology and Division of Infectious Diseases, Geneva University Hospital, Switzerland.

Matthias Cavassini (M)

Division of Infectious Diseases, Lausanne University Hospital, Switzerland.

Matthias Hoffmann (M)

Division of Infectious Diseases, Cantonal Hospital St Gallen, Switzerland.

Jürg Böni (J)

Institute of Medical Virology, University of Zurich, Switzerland.

Sabine Yerly (S)

Laboratory of Virology and Division of Infectious Diseases, Geneva University Hospital, Switzerland.

Thomas Klimkait (T)

Molecular Virology, Department of Biomedicine-Petersplatz, University of Basel, Switzerland.

Matthieu Perreau (M)

University of Lausanne, Bern University Hospital, Switzerland.

Andri Rauch (A)

Department of Infectious Diseases, Bern University Hospital, Switzerland.

Huldrych F Günthard (HF)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Switzerland.

Roger D Kouyos (RD)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Switzerland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH